Vinci Pharmaceuticals, Inc. — Form D
Vinci Pharmaceuticals, Inc. of Avon by the Sea, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2019-08-15. The offering totals $4.0M, of which $1.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2019-08-15
- Form: D
- Accession: 0001785495-19-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $1.0M
- Remaining: $3.0M
- Investors: 1
- Date of first sale: 2019-08-02
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-346670
Issuer
- Name: Vinci Pharmaceuticals, Inc.
- CIK: 0001785495
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 12 Washington Avenue, Avon by the Sea, NJ, 07717
- Phone: 914-582-8305
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Philip Gioia | Director | Avon by the Sea, NJ |
| Philip Gioia | Executive Officer | Avon by the Sea, NJ |
| Sarah Hassan | Director | Avon by the Sea, NJ |
| Richard Lindstrom | Director | Avon by the Sea, NJ |
| Sigurd Kirk | Director | Avon by the Sea, NJ |
| Neil Austrian Jr. | Director | Avon by the Sea, NJ |
Other filings by this issuer (1)
More